-
Why Johnson & Johnson's Strong Pharmaceutical Business Is A Concern
Tuesday, April 14, 2015 - 2:45pm | 392Johnson & Johnson (NYSE: JNJ) came out with better-than-expected earnings on Tuesday, despite the strong headwind it faced from the rising dollar. The company reported first-quarter EPS of $1.56, compared to $1.54 in the same quarter last year, while revenue dropped to $17.4 billion, from $18...